Coronavirus: AstraZeneca CEO hits back at ‘aggravated’ and ‘emotional’ EU
Pharmaceutical boss denies claim doses have been sold to higher bidder
AstraZeneca CEO Pascal Soriot has defended his company’s rollout of the Oxford Covid vaccine in the EU, describing its member states as “aggravated” and “emotional”.
After European leaders reacted with outrage at news that vaccine doses would be delayed, European Health Commissioner Stella Kyriakides said on Monday it was “not acceptable”, with Italy and Latvia threatening to sue the drugmaker.
Speaking to Italian newspaper La Repubblica, Soriot said the number that will be delivered is “not so bad”, adding that AstraZeneca only committed to meet demand to its “best effort”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Soriot also rejected the suggestions that his company had diverted doses meant for the EU to higher bidders, insisting “we make no profit everywhere” under the agreement signed with Oxford University.
“We’re certainly not taking vaccines away from the Europeans to sell it somewhere else at the profit,” he said. “It would not make sense.”
The interview also included two boosts for Boris Johnson, with the first coming when Soriot “rejected calls to divert doses to the European Union following a breakdown in supply”, The Guardian says.
“The UK agreement was reached in June, three months before the European one,” he told La Repubblica. “As you could imagine, the UK government said the supply coming out of the UK supply chain would go for the UK first. Basically, that’s how it is.”
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Soriot also gave his backing to the government’s strategy of delaying the second vaccine in order to get the first dose to people more quickly. “I think the UK one-dose strategy is absolutely the right way to go, at least for our vaccine,” he said.
“First of all, we believe that the efficacy of one dose is sufficient: 100% protection against severe disease and hospitalisation, and 71-73% of efficacy overall. The second dose is needed for long term protection. But you get a better efficiency if you get the second dose later than earlier.”
Create an account with the same email registered to your subscription to unlock access.
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
'Elevating Earth Day into a national holiday is not radical — it's practical'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
UAW scores historic win in South at VW plant
Speed Read Volkswagen workers in Tennessee have voted to join the United Auto Workers union
By Peter Weber, The Week US Published
-
Is David Cameron overshadowing Rishi Sunak?
Talking Point Current PM faces 'thorny dilemma' as predecessor enjoys return to world stage
By The Week UK Published
-
Less than total recall
Editor's Letter Why our brains want to forget the darkest days of the pandemic
By Theunis Bates Published
-
'A wonky bureaucratic tweak has dramatically changed how Americans drive'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
Will Aukus pact survive a second Trump presidency?
Today's Big Question US, UK and Australia seek to expand 'game-changer' defence partnership ahead of Republican's possible return to White House
By Sorcha Bradley, The Week UK Published
-
Can Boris Johnson save Rishi Sunak?
Today's Big Question Former PM could 'make the difference' between losing the next election and annihilation
By The Week UK Published
-
It's the economy, Sunak: has 'Rishession' halted Tory fightback?
Today's Big Question PM's pledge to deliver economic growth is 'in tatters' as stagnation and falling living standards threaten Tory election wipeout
By Harriet Marsden, The Week UK Published
-
Why your local council may be going bust
The Explainer Across England, local councils are suffering from grave financial problems
By The Week UK Published
-
Rishi Sunak and the right-wing press: heading for divorce?
Talking Point The Telegraph launches 'assault' on PM just as many Tory MPs are contemplating losing their seats
By Keumars Afifi-Sabet, The Week UK Published